Elevatus Welath Management’s Clorox CLX Stock Holding History

Elevatus Welath Management’s Portfolio CLX Stock Details CLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-18,415	Closed	-$2.93M	–	72
2023 Q2	$2.93M	Buy	+18,415	New	+$2.97M	2.03%	22

Other funds holding CLX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Elevatus Welath Management's CLX Position: Q3 2023 in Review

Elevatus Welath Management sold out of Clorox (CLX) in Q3 2023, closing a stake of 18,415 shares — an estimated $2.93M sold.

Elevatus Welath Management first reported a position in CLX in Q2 2023 and held it in 1 quarter. The position peaked at $2.93M in Q2 2023. 1,064 funds tracked by Wall St. Rank hold CLX as of Q3 2023.

Elevatus Welath Management reported no remaining Clorox position as of Q3 2023 after selling out during the quarter.
Elevatus Welath Management sold 18,415 Clorox shares in Q3 2023, an estimated $2.93M.
Elevatus Welath Management first reported a position in Clorox in Q2 2023 and held it in 1 quarter.
Elevatus Welath Management's Clorox position peaked at $2.93M in Q2 2023.
1,064 funds tracked by Wall St. Rank held Clorox as of Q3 2023.

Based on Elevatus Welath Management's 13F filing for Q3 2023, filed 14 Nov 2023.